We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Frequency of Use of Optive and Systane

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00406510
First Posted: December 4, 2006
Last Update Posted: June 1, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Innovative Medical
  Purpose
The purpose of this study is subjectively compare duration of action between Optive and Systane.

Condition Intervention Phase
Dry Eye Drug: Optive, Systane Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single

Resource links provided by NLM:


Further study details as provided by Innovative Medical:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • Males or females > 18 years old
  • Mild to moderate dry eye symptoms
  • Score of at least 2 and no more than 4 on the SESOD at the initial screening visit
  • Likely to complete all study visits and able to provide informed consent

Exclusion Criteria:

  • Current use of topical cyclosporine
  • Known contraindications to any study medication or ingredients
  • Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)
  • Ocular surgery within the past 3 months,
  • Active ocular allergies
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00406510


Locations
United States, California
Private Practice
Azusa, California, United States, 91702
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: Milton Hom, OD Private Practice
  More Information

ClinicalTrials.gov Identifier: NCT00406510     History of Changes
Other Study ID Numbers: 5283
First Submitted: November 30, 2006
First Posted: December 4, 2006
Last Update Posted: June 1, 2007
Last Verified: May 2007